Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

RecruitingOBSERVATIONAL
Enrollment

327

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ovarian Cancer
Trial Locations (24)

14076

RECRUITING

Centre François Baclesse, Caen

24004

RECRUITING

Clinique Francheville, Périgueux

25030

RECRUITING

CHRU Besançon - Hôpital Jean Minjoz, Besançon

31059

RECRUITING

Oncopole Claudius Regaud - IUCT Oncopole, Toulouse

31300

RECRUITING

Clinique Pasteur, Toulouse

33300

RECRUITING

Polyclinique Bordeaux Nord, Bordeaux

35042

RECRUITING

Centre Eugène Marquis, Rennes

38043

RECRUITING

CHU Grenoble-Alpes - Site Nord (La Tronche), Grenoble

44805

RECRUITING

ICO - Centre René Gauducheau, Saint-Herblain

49055

RECRUITING

ICO Paul Papin, Angers

54519

RECRUITING

ICL - Centre Alexis Vautrin, Vandœuvre-lès-Nancy

63011

RECRUITING

Centre Jean Perrin, Clermont-Ferrand

69495

RECRUITING

HCL - Centre Hospitalier Lyon Sud, Pierre-Bénite

75012

RECRUITING

Groupe Hospitalier Diaconesses - Croix Saint-Simon, Paris

75014

RECRUITING

Hôpital Cochin, Paris

75015

RECRUITING

Hôpital Européen Georges Pompidou, Paris

75248

RECRUITING

Institut Curie, Paris

84918

RECRUITING

Sainte-Catherine Institut du Cancer Avignon-Provence, Avignon

85925

RECRUITING

Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon

86021

RECRUITING

CHU de Poitiers - Hôpital de la Milétrie, Poitiers

94805

RECRUITING

Gustave Roussy, Villejuif

98012

RECRUITING

Centre Hospitalier Princesse Grace, Monaco

06250

RECRUITING

Centre Azuréen de Cancérologie, Mougins

Unknown

RECRUITING

Hôpital Privé du Confluent, Nantes

All Listed Sponsors
lead

ARCAGY/ GINECO GROUP

OTHER